<DOC>
	<DOCNO>NCT02980315</DOCNO>
	<brief_summary>The purpose study evaluate safety design LMP1－CAR －T cell determine whether CAR-T cell effective treatment EBV associate malignant tumor .</brief_summary>
	<brief_title>A New EBV Related Technologies T Cells Treating Malignant Tumors Clinical Application</brief_title>
	<detailed_description>Half patient treat LMP1-CAR-T cell , half receive placebo.During time treatment , supervise side effect treat group.At last compare survival rate health condition two group .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Clinical diagnosis nasopharyngeal carcinoma •pregnant woman severe autoimmune disease serious infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>EBV relate cancer</keyword>
</DOC>